MarketCap
Facebook
X
TelegramAnnual report 2023
added 12-27-2025
Profound Medical Corp. Operating Expenses 2011-2026 | PROF
Annual Operating Expenses Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33 M | 35.1 M | 33.2 M | 22.3 M | 17.3 M | 21 M | 19.5 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.1 M | 17.3 M | 25.9 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.19 B | $ 180.67 | 4.35 % | $ 13.5 B |  USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 11.25 | 3.21 % | $ 1.69 B | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 33.47 | 4.72 % | $ 1.54 B | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.32 | 1.23 % | $ 1.66 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.33 | 0.76 % | $ 125 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 288.17 | 3.19 % | $ 8.13 B | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.59 | -4.08 % | $ 36.7 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 39.05 | 3.88 % | $ 5.82 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.18 | 2.3 % | $ 93.5 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.01 | 15.32 % | $ 283 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.95 | 3.44 % | $ 211 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
547 M | $ 92.98 | 2.83 % | $ 12.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.03 | 7.41 % | $ 1.23 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.28 | 4.39 % | $ 906 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.45 | 1.9 % | $ 172 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | 3.01 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.95 | 6.14 % | $ 398 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.45 | 4.08 % | $ 374 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.73 | 6.34 % | $ 30.6 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 54.92 | 1.67 % | $ 1.61 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 38.46 | 4.68 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 64.58 | 2.87 % | $ 3.52 B |  Britain |
 |
LENSAR
LNSR
|
32.6 M | $ 5.92 | 3.86 % | $ 70.8 M | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 87.73 | 3.08 % | $ 3.05 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.71 | 0.16 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |